Loading company…
Mirata Pharmaceuticals researches and develops drugs intended to relieve pain.
Mirata Pharmaceuticals focuses on discovering and developing pain-relieving drugs, with the aim of addressing prescription opioid overdoses. Established in 2016 and based in the US, it raised USD 7.05 million in series A funding in October 2019 from Viva Ventures Biotech.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in